Table 3.

Patients with Stable, Increased, and Decreased BMD After 1 Year of Generic Alendronate Treatment

Location	BMD
	Increased	Stable	Decreased
Lumbar spinea	65 (67.0%)	22 (22.7%)	10 (10.3%)
Femoral neckb	26 (25.5%)	63 (61.8%)	13 (12.7%)
Total hipb	26 (25.5%)	66 (64.7%)	10 (9.8%)

Notes: Data are presented as numbers and percentages. ^aLumbar spine BMD was classified as increased if the amount of BMD gain was ≥3%, stable if the percentage change was between −3 and 3%, and decreased if the amount of BMD loss was ≥3%. ^bFemoral neck and total hip BMDs were categorized as increased if the amount of BMD gain was ≥5%, stable if the percentage change was between −5 and 5%, and decreased if the amount of BMD loss was ≥5%.